Literature DB >> 24792912

Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function.

Dror S Shouval1, Amlan Biswas1, Jeremy A Goettel1, Katelyn McCann2, Evan Conaway3, Naresh S Redhu1, Ivan D Mascanfroni4, Ziad Al Adham5, Sydney Lavoie6, Mouna Ibourk6, Deanna D Nguyen7, Janneke N Samsom8, Johanna C Escher9, Raz Somech10, Batia Weiss11, Rita Beier12, Laurie S Conklin13, Christen L Ebens14, Fernanda G M S Santos15, Alexandre R Ferreira15, Mary Sherlock16, Atul K Bhan17, Werner Müller18, J Rodrigo Mora7, Francisco J Quintana4, Christoph Klein19, Aleixo M Muise20, Bruce H Horwitz21, Scott B Snapper22.   

Abstract

Intact interleukin-10 receptor (IL-10R) signaling on effector and T regulatory (Treg) cells are each independently required to maintain immune tolerance. Here we show that IL-10 sensing by innate immune cells, independent of its effects on T cells, was critical for regulating mucosal homeostasis. Following wild-type (WT) CD4(+) T cell transfer, Rag2(-/-)Il10rb(-/-) mice developed severe colitis in association with profound defects in generation and function of Treg cells. Moreover, loss of IL-10R signaling impaired the generation and function of anti-inflammatory intestinal and bone-marrow-derived macrophages and their ability to secrete IL-10. Importantly, transfer of WT but not Il10rb(-/-) anti-inflammatory macrophages ameliorated colitis induction by WT CD4(+) T cells in Rag2(-/-)Il10rb(-/-) mice. Similar alterations in the generation and function of anti-inflammatory macrophages were observed in IL-10R-deficient patients with very early onset inflammatory bowel disease. Collectively, our studies define innate immune IL-10R signaling as a key factor regulating mucosal immune homeostasis in mice and humans.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24792912      PMCID: PMC4513358          DOI: 10.1016/j.immuni.2014.03.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  47 in total

1.  Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.

Authors:  Samuel Huber; Nicola Gagliani; Enric Esplugues; William O'Connor; Francis J Huber; Ashutosh Chaudhry; Masahito Kamanaka; Yasushi Kobayashi; Carmen J Booth; Alexander Y Rudensky; Maria Grazia Roncarolo; Manuela Battaglia; Richard A Flavell
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

2.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

Authors:  Ashutosh Chaudhry; Robert M Samstein; Piper Treuting; Yuqiong Liang; Marina C Pils; Jan-Michael Heinrich; Robert S Jack; F Thomas Wunderlich; Jens C Brüning; Werner Müller; Alexander Y Rudensky
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

3.  Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease.

Authors:  Bernadette Begue; Julien Verdier; Frédéric Rieux-Laucat; Olivier Goulet; Alain Morali; Danielle Canioni; Jean-Pierre Hugot; Cécile Daussy; Virginie Verkarre; Bénédicte Pigneur; Alain Fischer; Christoph Klein; Nadine Cerf-Bensussan; Frank M Ruemmele
Journal:  Am J Gastroenterol       Date:  2011-04-26       Impact factor: 10.864

Review 4.  IL-10 family of cytokines.

Authors:  Robert Sabat
Journal:  Cytokine Growth Factor Rev       Date:  2010-10       Impact factor: 7.638

5.  Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice.

Authors:  Bo Liu; Susan L Tonkonogy; R Balfour Sartor
Journal:  Gastroenterology       Date:  2011-04-30       Impact factor: 22.682

6.  Type I interferon inhibits interleukin-1 production and inflammasome activation.

Authors:  Greta Guarda; Marion Braun; Francesco Staehli; Aubry Tardivel; Chantal Mattmann; Irmgard Förster; Matthias Farlik; Thomas Decker; Renaud A Du Pasquier; Pedro Romero; Jürg Tschopp
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

7.  IL-10 controls dendritic cell-induced T-cell reactivation in the skin to limit contact hypersensitivity.

Authors:  Mathilde J H Girard-Madoux; Junda M Kel; Boris Reizis; Björn E Clausen
Journal:  J Allergy Clin Immunol       Date:  2011-10-05       Impact factor: 10.793

8.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.

Authors:  Andre Franke; Dermot P B McGovern; Jeffrey C Barrett; Kai Wang; Graham L Radford-Smith; Tariq Ahmad; Charlie W Lees; Tobias Balschun; James Lee; Rebecca Roberts; Carl A Anderson; Joshua C Bis; Suzanne Bumpstead; David Ellinghaus; Eleonora M Festen; Michel Georges; Todd Green; Talin Haritunians; Luke Jostins; Anna Latiano; Christopher G Mathew; Grant W Montgomery; Natalie J Prescott; Soumya Raychaudhuri; Jerome I Rotter; Philip Schumm; Yashoda Sharma; Lisa A Simms; Kent D Taylor; David Whiteman; Cisca Wijmenga; Robert N Baldassano; Murray Barclay; Theodore M Bayless; Stephan Brand; Carsten Büning; Albert Cohen; Jean-Frederick Colombel; Mario Cottone; Laura Stronati; Ted Denson; Martine De Vos; Renata D'Inca; Marla Dubinsky; Cathryn Edwards; Tim Florin; Denis Franchimont; Richard Gearry; Jürgen Glas; Andre Van Gossum; Stephen L Guthery; Jonas Halfvarson; Hein W Verspaget; Jean-Pierre Hugot; Amir Karban; Debby Laukens; Ian Lawrance; Marc Lemann; Arie Levine; Cecile Libioulle; Edouard Louis; Craig Mowat; William Newman; Julián Panés; Anne Phillips; Deborah D Proctor; Miguel Regueiro; Richard Russell; Paul Rutgeerts; Jeremy Sanderson; Miquel Sans; Frank Seibold; A Hillary Steinhart; Pieter C F Stokkers; Leif Torkvist; Gerd Kullak-Ublick; David Wilson; Thomas Walters; Stephan R Targan; Steven R Brant; John D Rioux; Mauro D'Amato; Rinse K Weersma; Subra Kugathasan; Anne M Griffiths; John C Mansfield; Severine Vermeire; Richard H Duerr; Mark S Silverberg; Jack Satsangi; Stefan Schreiber; Judy H Cho; Vito Annese; Hakon Hakonarson; Mark J Daly; Miles Parkes
Journal:  Nat Genet       Date:  2010-12       Impact factor: 38.330

9.  Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology.

Authors:  Masahito Kamanaka; Samuel Huber; Lauren A Zenewicz; Nicola Gagliani; Chozhavendan Rathinam; William O'Connor; Yisong Y Wan; Susumu Nakae; Yoichiro Iwakura; Liming Hao; Richard A Flavell
Journal:  J Exp Med       Date:  2011-04-25       Impact factor: 14.307

Review 10.  Interferon lambda: a new sword in cancer immunotherapy.

Authors:  Ahmed Lasfar; Walid Abushahba; Murugabaskar Balan; Karine A Cohen-Solal
Journal:  Clin Dev Immunol       Date:  2011-12-06
View more
  206 in total

Review 1.  The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis.

Authors:  Ido Amit; Deborah R Winter; Steffen Jung
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

Review 2.  ALOX15 as a suppressor of inflammation and cancer: Lost in the link.

Authors:  Rui Tian; Xiangsheng Zuo; Jonathan Jaoude; Fei Mao; Jennifer Colby; Imad Shureiqi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-01-13       Impact factor: 3.072

Review 3.  Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.

Authors:  Mei Lan Chen; Mark S Sundrud
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

4.  Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity.

Authors:  Yue Sun; Zhihong Wang; Huihui Chi; Qiongyi Hu; Junna Ye; Honglei Liu; Xiaobing Cheng; Hui Shi; Zhuochao Zhou; Jialin Teng; Chengde Yang; Yutong Su
Journal:  Clin Rheumatol       Date:  2019-06-21       Impact factor: 2.980

Review 5.  The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.

Authors:  Dror S Shouval; Matthew Kowalik; Scott B Snapper
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

Review 6.  Intestinal Antigen-Presenting Cells: Key Regulators of Immune Homeostasis and Inflammation.

Authors:  Kyle L Flannigan; Duke Geem; Akihito Harusato; Timothy L Denning
Journal:  Am J Pathol       Date:  2015-05-11       Impact factor: 4.307

7.  Systemic Corticosteroid Responses in Children with Severe Asthma: Phenotypic and Endotypic Features.

Authors:  Anne M Fitzpatrick; Susan T Stephenson; Milton R Brown; Khristopher Nguyen; Shaneka Douglas; Lou Ann S Brown
Journal:  J Allergy Clin Immunol Pract       Date:  2016-09-21

8.  Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency.

Authors:  Dror S Shouval; Amlan Biswas; Yu Hui Kang; Alexandra E Griffith; Liza Konnikova; Ivan D Mascanfroni; Naresh S Redhu; Sandra M Frei; Michael Field; Andria L Doty; Jeffrey D Goldsmith; Atul K Bhan; Anthony Loizides; Batia Weiss; Baruch Yerushalmi; Tadahiro Yanagi; Xiuli Lui; Francisco J Quintana; Aleixo M Muise; Christoph Klein; Bruce H Horwitz; Sarah C Glover; Athos Bousvaros; Scott B Snapper
Journal:  Gastroenterology       Date:  2016-09-28       Impact factor: 22.682

Review 9.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

Authors:  Ankit Saxena; Sam Khosraviani; Sanjeev Noel; Divya Mohan; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cytokine       Date:  2014-12-04       Impact factor: 3.861

10.  Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses.

Authors:  Claire Gorby; Junel Sotolongo Bellón; Stephan Wilmes; Walid Warda; Elizabeth Pohler; Paul K Fyfe; Adeline Cozzani; Christophe Ferrand; Mark R Walter; Suman Mitra; Jacob Piehler; Ignacio Moraga
Journal:  Sci Signal       Date:  2020-09-15       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.